The NHS prioritises safety and effectiveness, so regular check-ins and monitoring will be a part of your routine
In clinical trials, those who took Semaglutide lost an average of 15% of their body weight, compared to just 2.4% in the placebo group
Weight loss may also influence cardiovascular function in some patients, potentially contributing to awareness of heart rate changes
So I'm going to cover those questions for you today
Ryan PM, Seltzer S, Hayward NE, Rodriguez DA, Sless RT, Hawkes CP
Factors that influence results include: Metabolism Diet and nutrition habits Physical activity levels Hormonal health Underlying medical conditions Some patients respond extremely well to semaglutide, while others may see better results with tirzepatide